Skip to content

Blood Collection for COM/BSBS

Blood Collection for Use with Translational, Biomedical Research At UCF College of Medicine and Burnett School of Biomedical Sciences

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06082661
Enrollment
5000
Registered
2023-10-13
Start date
2022-06-23
Completion date
2027-06-30
Last updated
2024-12-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

Blood, Healthy

Brief summary

The objective of this biospecimen collection protocol is the acquisition of blood from adult volunteers. These biospecimens will be transferred to the College of Medicine (COM)/Burnett School of Biomedical Sciences (BSBS) research scientists and their research teams for testing according to their separate IRB-approved/exempted protocols. These separate IRBapproved protocols cannot be for genetic testing.

Detailed description

Research scientists of the University of Central Florida College of Medicine (COM) and Burnett School of Biomedical Sciences (BSBS) conduct laboratory studies in biomedical and translational research for the purpose of understanding human disease and developing innovative methods for diagnosing, measuring, or treating disease or disease symptoms. The key research divisions are cancer, cardiovascular, immunity and pathogenesis, neuroscience, and molecular microbiology. Frequently, these studies require human blood (or its derivatives) for testing of assays and devices.

Interventions

None listed

Sponsors

University of Central Florida
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Male or female adults * 18 years old or older * weigh over 110 pounds * able to provide informed consent

Exclusion criteria

* pregnant/suspect to be pregnant * prisoners * have donated blood anywhere in the preceding 16 weeks

Design outcomes

Primary

MeasureTime frameDescription
Acquisition of blood samples for testing5 yearsThis is a non-clinical, biospecimen collection study.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026